Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Eight new option listings and seven option delistings on February 3rd » 08:30
02/03/20
02/03
08:30
02/03/20
08:30
CCAP

Crescent BDC

$0.00 /

+ (+0.00%)

, FDEF

First Defiance Financial

$29.54 /

-0.74 (-2.44%)

, GAIA

Gaia

$8.46 /

-0.29 (-3.31%)

, LSXMK

Liberty Sirius XM

$48.98 /

-0.73 (-1.47%)

, WTRG

Essential Utilities

$51.98 /

-0.345 (-0.66%)

, ABDC

Alcentra Capital

$8.83 /

-0.36 (-3.92%)

, BIOS

Symbol changed to OPCH

/

+

, CISN

Cision

$10.00 /

+ (+0.00%)

, FII

Changed to FHI

/

+

, UCFC

United Community Financial

$10.97 /

-0.23 (-2.05%)

, WTR

Aqua America

$0.00 /

+ (+0.00%)

, XON

Intrexon

/

+

New option listings for…

New option listings for February 3rd include Crescent Capital BDC (CCAP), First Defiance Financial (FDEF), Federated Hermes Inc (Class B Stock) (FHI), Gaia (GAIA), Liberty Media-Series C Stock (LSXMK), Option Care Health Inc (OPCH), Precigen Inc (PGEN), and Essential Utilities Inc (WTRG). Option delistings effective February 3rd include Alcentra Capital Corporation (ABDC), Option Care Health Inc (BIOS), Cision Ltd (CISN), Federated Investors Inc (Class B Stock) (FII), United Community Financial Corporation (UCFC), Aqua America Inc (WTR), and Intrexon Corporation (XON).

ShowHide Related Items >><<
CCAP Crescent BDC
$0.00 /

+ (+0.00%)

FDEF First Defiance Financial
$29.54 /

-0.74 (-2.44%)

09/11/19 Raymond James
United Community downgraded at Raymond James following merger agreement
09/11/19 Sandler O'Neill
First Defiance Financial upgraded to Buy from Hold at Sandler O'Neill
09/11/19 Raymond James
United Community downgraded to Market Perform from Outperform at Raymond James
GAIA Gaia
$8.46 /

-0.29 (-3.31%)

08/06/19 Lake Street
Gaia price target lowered to $15 from $20 at Lake Street
06/17/19 B. Riley FBR
Brunswick added to Alpha Generator list, Gaia removed, at B. Riley FBR
03/05/19 Lake Street
Gaia price target lowered to $20 from $28 at Lake Street
03/01/19 B. Riley FBR
B. Riley adds Gaia, removes TiVo from Alpha Generator list
LSXMK Liberty Sirius XM
$48.98 /

-0.73 (-1.47%)

03/15/19 Morgan Stanley
Liberty Sirius XM resumed with an Overweight at Morgan Stanley
03/15/19 Morgan Stanley
Sirius XM resumed with an Equal Weight at Morgan Stanley
WTRG Essential Utilities
$51.98 /

-0.345 (-0.66%)

ABDC Alcentra Capital
$8.83 /

-0.36 (-3.92%)

BIOS Symbol changed to OPCH
/

+

01/07/20 William Blair
Option Care Health initiated with an Outperform at William Blair
08/05/19 Lake Street
BioScrip not the acquirer in merger, which is positive, says Lake Street
07/15/19 Lake Street
CMS funding potential 'meaningful positive' for BioScrip, says Lake Street
03/18/19 Canaccord
Canaccord, while disappointed with merger terms, remains buyer of BioScrip
CISN Cision
$10.00 /

+ (+0.00%)

10/23/19 Truist
Cision downgraded to Hold from Buy at SunTrust
10/23/19 RBC Capital
Cision downgraded to Sector Perform from Outperform at RBC Capital
10/23/19 William Blair
Cision downgraded to Market Perform from Outperform at William Blair
10/23/19 Citi
Cision downgraded to Neutral from Buy at Citi
FII Changed to FHI
/

+

12/13/19 JPMorgan
JPMorgan downgrades Federated Investors to Neutral, cuts target to $36
12/13/19 JPMorgan
Federated Investors downgraded to Neutral from Overweight at JPMorgan
12/05/19 Evercore ISI
Federated Investors initiated with an Outperform at Evercore ISI
06/10/19 JPMorgan
JPMorgan upgrades Federated to Overweight on money market growth
UCFC United Community Financial
$10.97 /

-0.23 (-2.05%)

04/17/19 Keefe Bruyette
United Community selloff brings good buying opportunity, says Keefe Bruyette
WTR Aqua America
$0.00 /

+ (+0.00%)

01/21/20 BofA
Aqua America downgraded to Neutral from Buy at BofA
12/30/19 Argus
Aqua America offers solid business model, steady earnings, says Argus
09/30/19 Argus
Aqua America price target raised to $50 from $43 at Argus
08/08/19 UBS
Aqua America downgraded to Neutral from Buy at UBS
XON Intrexon
/

+

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
Conference/Events
EBDF Group to hold a conference » 04:55
01/15/20
01/15
04:55
01/15/20
04:55
A

Agilent

$88.02 /

+0.565 (+0.65%)

, AGE

AgeX Therapeutics

$1.85 /

+0.13 (+7.56%)

, ALNY

Alnylam

$118.48 /

+3.68 (+3.21%)

, AZN

AstraZeneca

$50.18 /

+0.5 (+1.01%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.34 /

-0.04 (-0.91%)

, ENTX

Entera Bio

$2.78 /

-0.03 (-1.07%)

, DYAI

Dyadic International

$5.50 /

-0.135 (-2.40%)

, DTIL

Precision BioSciences

$13.40 /

-0.12 (-0.89%)

, DD

DuPont

$60.16 /

-0.25 (-0.41%)

, CYCC

Cyclacel Pharmaceuticals

$0.74 /

-0.0549 (-6.91%)

, CTLT

Catalent

$60.34 /

+0.88 (+1.48%)

, COWN

Cowen Group

$16.34 /

-0.2 (-1.21%)

, GMAB

Genmab

$22.44 /

-0.21 (-0.93%)

, IDXG

Interpace Biosciences

$0.62 /

+ (+0.00%)

, LCTX

Lineage Cell Therapeutics

$0.75 /

-0.0146 (-1.92%)

, PHIO

Phio Pharmaceuticals

$0.20 /

+0.0117 (+6.35%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.48 /

+0.03 (+2.07%)

, TROV

Changed name to CRDF

$1.47 /

+0.15 (+11.41%)

, VCYT

Veracyte

$28.58 /

+0.17 (+0.60%)

, VIE

Viela Bio

$37.10 /

+4.17 (+12.66%)

, PSTV

Plus Therapeutics

$2.81 /

+0.02 (+0.72%)

, RDUS

Radius Health

$20.14 /

+1.77 (+9.64%)

, MRNA

Moderna

$20.01 /

-0.21 (-1.04%)

, MRK

Merck

$89.93 /

+0.5 (+0.56%)

, NAVB

Navidea

$1.49 /

-0.03 (-1.97%)

, NBSE

NeuBase Therapeutics

$6.31 /

-0.19 (-2.92%)

, NVO

Novo Nordisk

$59.62 /

+0.66 (+1.12%)

, NVS

Novartis

$94.47 /

+0.765 (+0.82%)

, OVID

Ovid Therapeutics

$3.59 /

+0.09 (+2.57%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$7.20 /

+0.46 (+6.82%)

, SLRX

Salarius Pharmaceuticals

$3.20 /

+0.15 (+4.92%)

, VVUS

VIVUS

$2.72 /

-0.01 (-0.37%)

, SIVB

SVB Financial

$253.42 /

-0.36 (-0.14%)

, VRML

Vermillion

$0.79 /

-0.0453 (-5.39%)

, VKTX

Viking Therapeutics

$7.36 /

+0.045 (+0.62%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$88.02 /

+0.565 (+0.65%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.85 /

+0.13 (+7.56%)

ALNY Alnylam
$118.48 /

+3.68 (+3.21%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$50.18 /

+0.5 (+1.01%)

01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan
12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.34 /

-0.04 (-0.91%)

ENTX Entera Bio
$2.78 /

-0.03 (-1.07%)

DYAI Dyadic International
$5.50 /

-0.135 (-2.40%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$13.40 /

-0.12 (-0.89%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$60.16 /

-0.25 (-0.41%)

01/14/20
Fly Intel: Top five analyst initiations
01/14/20 BMO Capital
DuPont price target lowered to $82 from $87 at BMO Capital
01/14/20 Gordon Haskett
DuPont initiated with a Buy at Gordon Haskett
01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
CYCC Cyclacel Pharmaceuticals
$0.74 /

-0.0549 (-6.91%)

CTLT Catalent
$60.34 /

+0.88 (+1.48%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.34 /

-0.2 (-1.21%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.44 /

-0.21 (-0.93%)

01/13/20 Truist
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.62 /

+ (+0.00%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.75 /

-0.0146 (-1.92%)

PHIO Phio Pharmaceuticals
$0.20 /

+0.0117 (+6.35%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.48 /

+0.03 (+2.07%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.47 /

+0.15 (+11.41%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.58 /

+0.17 (+0.60%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$37.10 /

+4.17 (+12.66%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.81 /

+0.02 (+0.72%)

RDUS Radius Health
$20.14 /

+1.77 (+9.64%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$20.01 /

-0.21 (-1.04%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.93 /

+0.5 (+0.56%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.49 /

-0.03 (-1.97%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$6.31 /

-0.19 (-2.92%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$59.62 /

+0.66 (+1.12%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 Truist
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$94.47 /

+0.765 (+0.82%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.59 /

+0.09 (+2.57%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$7.20 /

+0.46 (+6.82%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.20 /

+0.15 (+4.92%)

VVUS VIVUS
$2.72 /

-0.01 (-0.37%)

SIVB SVB Financial
$253.42 /

-0.36 (-0.14%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.79 /

-0.0453 (-5.39%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.36 /

+0.045 (+0.62%)

11/21/19 Truist
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Conference/Events
EBDF Group to hold a conference » 04:55
01/14/20
01/14
04:55
01/14/20
04:55
A

Agilent

$87.45 /

-0.19 (-0.22%)

, AGE

AgeX Therapeutics

$1.72 /

-0.15 (-8.02%)

, ALNY

Alnylam

$114.80 /

-4.57 (-3.83%)

, AZN

AstraZeneca

$49.68 /

-0.17 (-0.34%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.38 /

+0.01 (+0.23%)

, ENTX

Entera Bio

$2.81 /

+0.13 (+4.85%)

, DYAI

Dyadic International

$5.64 /

-0.055 (-0.97%)

, DTIL

Precision BioSciences

$13.52 /

-1.19 (-8.09%)

, DD

DuPont

$60.41 /

+0.7 (+1.17%)

, CYCC

Cyclacel Pharmaceuticals

$0.80 /

-0.115 (-12.64%)

, CTLT

Catalent

$59.46 /

+1.77 (+3.07%)

, COWN

Cowen Group

$16.54 /

+0.24 (+1.47%)

, GMAB

Genmab

$22.65 /

-0.02 (-0.09%)

, IDXG

Interpace Biosciences

$0.62 /

-0.0289 (-4.45%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.002 (-0.26%)

, PHIO

Phio Pharmaceuticals

$0.18 /

-0.0225 (-10.95%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.45 /

-0.14 (-8.81%)

, TROV

Changed name to CRDF

$1.32 /

+0.075 (+6.05%)

, VCYT

Veracyte

$28.41 /

-0.49 (-1.70%)

, VIE

Viela Bio

$32.93 /

+2.84 (+9.44%)

, PSTV

Plus Therapeutics

$2.79 /

-0.05 (-1.76%)

, RDUS

Radius Health

$18.37 /

-1.05 (-5.41%)

, MRNA

Moderna

$20.22 /

+1.12 (+5.86%)

, MRK

Merck

$89.43 /

-0.08 (-0.09%)

, NAVB

Navidea

$1.52 /

+ (+0.00%)

, NBSE

NeuBase Therapeutics

$6.50 /

-0.51 (-7.28%)

, NVO

Novo Nordisk

$58.96 /

+0.27 (+0.46%)

, NVS

Novartis

$93.71 /

-0.165 (-0.18%)

, OVID

Ovid Therapeutics

$3.50 /

-0.35 (-9.09%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.74 /

+0.3 (+4.66%)

, SLRX

Salarius Pharmaceuticals

$3.05 /

-0.58 (-15.98%)

, VVUS

VIVUS

$2.73 /

-0.065 (-2.33%)

, SIVB

SVB Financial

$253.78 /

+1.99 (+0.79%)

, VRML

Vermillion

$0.84 /

+0.036 (+4.48%)

, VKTX

Viking Therapeutics

$7.31 /

-0.4 (-5.19%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$87.45 /

-0.19 (-0.22%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.72 /

-0.15 (-8.02%)

ALNY Alnylam
$114.80 /

-4.57 (-3.83%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$49.68 /

-0.17 (-0.34%)

01/13/20 Roth Capital
Amarin's Vascepa now the 'go-to' after competitor failures, says Roth Capital
01/13/20 Stifel
Amarin should rally on failure of two potential competitors, says Stifel
01/13/20 JPMorgan
Epanova discontinuation positive for Amarin, says JPMorgan
12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.38 /

+0.01 (+0.23%)

ENTX Entera Bio
$2.81 /

+0.13 (+4.85%)

DYAI Dyadic International
$5.64 /

-0.055 (-0.97%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$13.52 /

-1.19 (-8.09%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$60.41 /

+0.7 (+1.17%)

01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
12/18/19 DZ Bank
DuPont upgraded to Buy from Hold at DZ Bank
12/17/19 JPMorgan
IFF shares can rally 50% over three years, says JPMorgan
12/17/19 Jefferies
DuPont price target lowered to $79 from $85 at Jefferies
CYCC Cyclacel Pharmaceuticals
$0.80 /

-0.115 (-12.64%)

CTLT Catalent
$59.46 /

+1.77 (+3.07%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.54 /

+0.24 (+1.47%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.65 /

-0.02 (-0.09%)

01/13/20 Truist
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.62 /

-0.0289 (-4.45%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.76 /

-0.002 (-0.26%)

PHIO Phio Pharmaceuticals
$0.18 /

-0.0225 (-10.95%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.45 /

-0.14 (-8.81%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.32 /

+0.075 (+6.05%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.41 /

-0.49 (-1.70%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$32.93 /

+2.84 (+9.44%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.79 /

-0.05 (-1.76%)

RDUS Radius Health
$18.37 /

-1.05 (-5.41%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$20.22 /

+1.12 (+5.86%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.43 /

-0.08 (-0.09%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.52 /

+ (+0.00%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$6.50 /

-0.51 (-7.28%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$58.96 /

+0.27 (+0.46%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 Truist
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$93.71 /

-0.165 (-0.18%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.50 /

-0.35 (-9.09%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$6.74 /

+0.3 (+4.66%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.05 /

-0.58 (-15.98%)

VVUS VIVUS
$2.73 /

-0.065 (-2.33%)

SIVB SVB Financial
$253.78 /

+1.99 (+0.79%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.84 /

+0.036 (+4.48%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.31 /

-0.4 (-5.19%)

11/21/19 Truist
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Conference/Events
EBDF Group to hold a conference » 08:42
01/13/20
01/13
08:42
01/13/20
08:42
A

Agilent

$87.64 /

+0.32 (+0.37%)

, AGE

AgeX Therapeutics

$1.87 /

-0.01 (-0.53%)

, ALNY

Alnylam

$119.37 /

+1.36 (+1.15%)

, AZN

AstraZeneca

$49.85 /

-0.24 (-0.48%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BCLI

BrainStorm

$4.37 /

+0.02 (+0.46%)

, ENTX

Entera Bio

$2.68 /

+0.08 (+3.08%)

, DYAI

Dyadic International

$5.69 /

+0.36 (+6.75%)

, DTIL

Precision BioSciences

$14.71 /

+0.02 (+0.14%)

, DD

DuPont

$59.71 /

-1.25 (-2.05%)

, CYCC

Cyclacel Pharmaceuticals

$0.91 /

+0.1578 (+20.98%)

, CTLT

Catalent

$57.69 /

+0.73 (+1.28%)

, COWN

Cowen Group

$16.30 /

-0.25 (-1.51%)

, GMAB

Genmab

$22.67 /

+ (+0.00%)

, IDXG

Interpace Biosciences

$0.65 /

+0.0189 (+3.00%)

, LCTX

Lineage Cell Therapeutics

$0.76 /

-0.018 (-2.31%)

, PHIO

Phio Pharmaceuticals

$0.21 /

-0.023 (-9.83%)

, PJC

Symbol now PIPR

$0.00 /

+ (+0.00%)

, TNXP

Tonix Pharmaceuticals

$1.59 /

+ (+0.00%)

, TROV

Changed name to CRDF

$1.24 /

-0.02 (-1.59%)

, VCYT

Veracyte

$28.90 /

+0.45 (+1.58%)

, VIE

Viela Bio

$30.09 /

+1.07 (+3.69%)

, PSTV

Plus Therapeutics

$2.84 /

+0.13 (+4.80%)

, RDUS

Radius Health

$19.42 /

-1.07 (-5.22%)

, MRNA

Moderna

$19.10 /

+0.71 (+3.86%)

, MRK

Merck

$89.51 /

+0.11 (+0.12%)

, NAVB

Navidea

$1.52 /

+0.005 (+0.33%)

, NBSE

NeuBase Therapeutics

$7.01 /

-0.36 (-4.88%)

, NVO

Novo Nordisk

$58.69 /

+1.25 (+2.18%)

, NVS

Novartis

$93.87 /

-0.88 (-0.93%)

, OVID

Ovid Therapeutics

$3.85 /

-0.18 (-4.47%)

, STI

Merged to become TFC

$0.00 /

+ (+0.00%)

, XON

Intrexon

$6.44 /

+0.14 (+2.22%)

, SLRX

Salarius Pharmaceuticals

$3.63 /

+0.03 (+0.83%)

, VVUS

VIVUS

$2.79 /

-0.03 (-1.06%)

, SIVB

SVB Financial

$251.79 /

-4.15 (-1.62%)

, VRML

Vermillion

$0.80 /

-0.016 (-1.95%)

, VKTX

Viking Therapeutics

$7.71 /

-0.02 (-0.26%)

Biotech Showcase 2020…

Biotech Showcase 2020 will be held in San Francisco on January 13-15.

ShowHide Related Items >><<
A Agilent
$87.64 /

+0.32 (+0.37%)

01/07/20 Wells Fargo
Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector
01/07/20 Wells Fargo
Agilent initiated with an Overweight at Wells Fargo
01/06/20 Citi
Agilent initiated with a Neutral at Citi
11/26/19 JPMorgan
Agilent price target raised to $90 from $85 at JPMorgan
AGE AgeX Therapeutics
$1.87 /

-0.01 (-0.53%)

ALNY Alnylam
$119.37 /

+1.36 (+1.15%)

12/18/19 Cantor Fitzgerald
Alnylam price target raised to $176 from $159 at Cantor Fitzgerald
12/17/19 Piper Sandler
Alnylam price target raised to $155 from $145 at Piper Jaffray
11/25/19 Stifel
Alnylam one of few mid-caps with 'plausible large-cap aspirations,' says Stifel
11/25/19 BMO Capital
Alnylam price target raised to $143 from $138 at BMO Capital
AZN AstraZeneca
$49.85 /

-0.24 (-0.48%)

12/26/19 Stifel
Stifel sees path to $230 for Iqvia shares after 'significant' AstraZeneca win
12/19/19 Baird
AstraZeneca deal a 'landmark win' for Iqvia OCE solution, says Baird
12/19/19 KeyBanc
Iqvia win at AstraZeneca at loss for Veeva, says KeyBanc
12/16/19 Stifel
Stifel 'taking profits' on Amarin following FDA approval, downgrades to Hold
BAYRY Bayer
$0.00 /

+ (+0.00%)

12/19/19 BofA
Elanco upgraded to Buy from Neutral at BofA/Merrill
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
12/17/19 Berenberg
Bayer upgraded to Buy from Hold at Berenberg
10/21/19 Piper Sandler
Piper reiterates Overweight on Crispr Therapeutics with $100 price target
BCLI BrainStorm
$4.37 /

+0.02 (+0.46%)

ENTX Entera Bio
$2.68 /

+0.08 (+3.08%)

DYAI Dyadic International
$5.69 /

+0.36 (+6.75%)

10/16/19 Dawson James
Dyadic International initiated with a Buy at Dawson James
DTIL Precision BioSciences
$14.71 /

+0.02 (+0.14%)

09/16/19 H.C. Wainwright
Precision IND accepted a quarter sooner than expected, says H.C. Wainwright
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
08/09/19 BTIG
Precision BioSciences initiated with a Buy at BTIG
04/22/19 Jefferies
Precision BioSciences initiated with a Buy at Jefferies
DD DuPont
$59.71 /

-1.25 (-2.05%)

01/08/20 Spin-Off Research
DuPont upgraded to Buy from Hold at Spin-Off Research
12/18/19 DZ Bank
DuPont upgraded to Buy from Hold at DZ Bank
12/17/19 JPMorgan
IFF shares can rally 50% over three years, says JPMorgan
12/17/19 Jefferies
DuPont price target lowered to $79 from $85 at Jefferies
CYCC Cyclacel Pharmaceuticals
$0.91 /

+0.1578 (+20.98%)

CTLT Catalent
$57.69 /

+0.73 (+1.28%)

10/17/19 Stephens
Catalent resumed with an Overweight at Stephens
08/28/19
Fly Intel: Top five analyst downgrades
08/28/19 Baird
Catalent price target raised to $60 from $50 at Baird
08/28/19
Catalent downgraded to Sector Weight on valuation at KeyBanc
COWN Cowen Group
$16.30 /

-0.25 (-1.51%)

07/23/19 Buckingham
Cowen Group initiated with a Buy at Buckingham
GMAB Genmab
$22.67 /

+ (+0.00%)

01/13/20 Truist
Genmab initiated with a Buy at SunTrust
01/02/20 Guggenheim
Incyte downgraded to Neutral after strong 2019 at Guggenheim
12/12/19 Deutsche Bank
Genmab downgraded to Hold from Buy at Deutsche Bank
10/04/19 Guggenheim
Guggenheim positively biased on Biotech heading into earnings
IDXG Interpace Biosciences
$0.65 /

+0.0189 (+3.00%)

09/25/19 Oppenheimer
Oppenheimer starts Interpace at Outperform, sees 'clear path to BioPharma'
09/25/19 Oppenheimer
Interpace Diagnostics initiated with an Outperform at Oppenheimer
LCTX Lineage Cell Therapeutics
$0.76 /

-0.018 (-2.31%)

PHIO Phio Pharmaceuticals
$0.21 /

-0.023 (-9.83%)

PJC Symbol now PIPR
$0.00 /

+ (+0.00%)

10/04/19 Buckingham
Piper Jaffray initiated with a Neutral at Buckingham
10/04/19 Buckingham
Piper Jaffray initiated with a Neutral rating at Buckingham
TNXP Tonix Pharmaceuticals
$1.59 /

+ (+0.00%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
04/18/19
Tonix Pharmaceuticals upgraded to Buy at Roth Capital
04/18/19 Roth Capital
Tonix Pharmaceuticals upgraded to Buy from Neutral at Roth Capital
TROV Changed name to CRDF
$1.24 /

-0.02 (-1.59%)

03/01/19 Maxim
Trovagene price target lowered to $8 from $18 at Maxim
VCYT Veracyte
$28.90 /

+0.45 (+1.58%)

12/04/19 Lake Street
Veracyte answered key question with NanoString pact, says Lake Street
07/31/19
Fly Intel: Top five analyst initiations
07/31/19 Lake Street
Veracyte initiated with a Buy at Lake Street
07/02/19
Fly Intel: Top five analyst initiations
VIE Viela Bio
$30.09 /

+1.07 (+3.69%)

10/28/19 Guggenheim
Guggenheim starts Viela Bio at Buy, makes stock Best Idea
10/28/19 Morgan Stanley
Viela Bio initiated with an Overweight at Morgan Stanley
10/28/19 Cowen
Viela Bio initiated with an Outperform at Cowen
10/28/19 Goldman Sachs
Viela Bio initiated with a Buy at Goldman Sachs
PSTV Plus Therapeutics
$2.84 /

+0.13 (+4.80%)

RDUS Radius Health
$19.42 /

-1.07 (-5.22%)

11/06/19 SVB Leerink
Radius Health price target lowered to $35 from $49 at SVB Leerink
08/29/19 Citi
Radius Health upgraded to Buy from Neutral at Citi
05/30/19 Citi
Radius Health assumed with a Neutral at Citi
05/29/19 Goldman Sachs
Radius Health upgraded to Buy from Neutral at Goldman Sachs
MRNA Moderna
$19.10 /

+0.71 (+3.86%)

01/10/20 Roth Capital
Moderna 'inching closer to a blockbuster CMV vaccine,' says Roth Capital
12/03/19 BofA
Moderna resumed with a Buy at BofA/Merrill
10/25/19 Roth Capital
Moderna initiated with a Buy at Roth Capital
09/13/19 Piper Sandler
Moderna price target raised to $32 from $30 at Piper Jaffray
MRK Merck
$89.51 /

+0.11 (+0.12%)

01/07/20
Fly Intel: Top five analyst initiations
01/07/20 SVB Leerink
OS miss in 1L SCLC 'a disappointing start to 2020' for Merck, says SVB Leerink
01/06/20 RBC Capital
Merck initiated with a Sector Perform at RBC Capital
12/18/19 Morgan Stanley
Morgan Stanley upgrades Major Pharmaceuticals sector view to Attractive
NAVB Navidea
$1.52 /

+0.005 (+0.33%)

11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
07/11/19
Fly Intel: Top five analyst initiations
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
07/11/19 Maxim
Navidea initiated with a Buy at Maxim
NBSE NeuBase Therapeutics
$7.01 /

-0.36 (-4.88%)

11/20/19 Oppenheimer
NeuBase Therapeutics initiated with an Outperform at Oppenheimer
10/29/19 H.C. Wainwright
NeuBase Therapeutics initiated with a Buy at H.C. Wainwright
09/24/19 BTIG
NeuBase Therapeutics initiated with a Buy at BTIG
NVO Novo Nordisk
$58.69 /

+1.25 (+2.18%)

01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral on continued insulin headwinds at Guggenheim
01/03/20 Guggenheim
Novo Nordisk downgraded to Neutral from Buy at Guggenheim
11/22/19 Pareto
Novo Nordisk downgraded to Hold from Buy at Pareto
11/19/19 Truist
Dicerna price target raised to $28 from $24 at SunTrust
NVS Novartis
$93.87 /

-0.88 (-0.93%)

01/06/20 JPMorgan
JPMorgan upgrades Sanofi to Overweight on 'unjustified' valuation gap
12/18/19 H.C. Wainwright
Aduro Biotech price target lowered to $4 from $7 at H.C. Wainwright
12/16/19 Evercore ISI
Evercore downgrades Regeneron on Eylea risk from Beovu
12/16/19
Novartis ends development of fevipiprant in asthma after Phase III failure
OVID Ovid Therapeutics
$3.85 /

-0.18 (-4.47%)

09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
09/23/19 Piper Sandler
Piper says Ovid shares reflect little value for 'exciting' soticlestat program
09/04/19 RBC Capital
Ovid Therapeutics initiated with an Outperform at RBC Capital
03/10/19 Piper Sandler
Ovid Therapeutics price target lowered to $14 from $20 at Piper Jaffray
STI Merged to become TFC
$0.00 /

+ (+0.00%)

12/09/19 RBC Capital
PNC Financial downgraded to Outperform from Top Pick at RBC Capital
11/20/19 Janney Montgomery Scott
SunTrust downgraded to Neutral from Buy at Janney Montgomery Scott
11/11/19 Janney Montgomery Scott
Janney Montgomery Scott downgrades BB&T to Neutral, says premium may 'flatten'
10/08/19 Jefferies
Jefferies changes five bank ratings after looking into 2020, 2021
XON Intrexon
$6.44 /

+0.14 (+2.22%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
SLRX Salarius Pharmaceuticals
$3.63 /

+0.03 (+0.83%)

VVUS VIVUS
$2.79 /

-0.03 (-1.06%)

SIVB SVB Financial
$251.79 /

-4.15 (-1.62%)

01/09/20 BofA
SVB Financial named top pick for 2020 at BofA
01/09/20 BofA
Amazaon, Wix.com, & SVB Financial added to US 1 List at BofA
01/02/20 Truist
SunTrust raises price targets on select regional banks on improved margins
08/13/19 JPMorgan
JPMorgan sees 'tremendous buying opportunity' into SVB Financial shares
VRML Vermillion
$0.80 /

-0.016 (-1.95%)

12/16/19
Vermillion management to meet with William Blair
VKTX Viking Therapeutics
$7.71 /

-0.02 (-0.26%)

11/21/19 Truist
Viking posting for VOYAGER includes 'nothing concerning,' says SunTrust
07/15/19 Oppenheimer
Viking Therapeutics initiated with an Outperform at Oppenheimer
06/25/19 Stifel
Viking Therapeutics initiated with a Buy at Stifel
06/25/19 Stifel
Madrigal Pharmaceuticals initiated with a Hold at Stifel
Hot Stocks
Darling Ingredients acquires 50% JV interest of EnviroFlight from Intrexon » 10:35
01/02/20
01/02
10:35
01/02/20
10:35
DAR

Darling Ingredients

$27.88 /

-0.22 (-0.78%)

, XON

Intrexon

$5.74 /

+0.27 (+4.94%)

Darling Ingredients (DAR)…

Darling Ingredients (DAR) announced that it has acquired the 50% joint venture interest of EnviroFlight, LLC owned by Intrexon Corporation (XON), thereby increasing its ownership interest in EnviroFlight to 100%. Enviroflight opened the first commercial BSF facility in Maysville, Kentucky in late 2018. Phase 1 of this production facility currently has the capacity to produce 900 tons of dried BSF larvae on an annual basis. "Expanding our ownership of EnviroFlight empowers us to accelerate our ability to create higher value, sustainable specialty proteins for the agriculture and companion animal feed industries," said Randall C. Stuewe, Chairman and CEO of Darling Ingredients. "Our purpose is to repurpose, and growing insects for specialty feed ingredients yields 10 times the usable protein per acre compared to producing algae and is at least 50 times the protein per acre compared to soy," Stuewe added. "We welcome the 62 EnviroFlight team members to the Darling Ingredients family."

ShowHide Related Items >><<
DAR Darling Ingredients
$27.88 /

-0.22 (-0.78%)

12/17/19 Roth Capital
Biodiesel tax credit extension much better than expected, says Roth Capital
09/25/19
Darling Ingredients management to meet with Roth Capital
07/12/19 Baird
Darling Ingredients named a Fresh Pick at Baird
XON Intrexon
$5.74 /

+0.27 (+4.94%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
Hot Stocks
Intrexon refocuses on healthcare, appoints Helen Sabzevari CEO and changes name » 08:02
01/02/20
01/02
08:02
01/02/20
08:02
XON

Intrexon

$5.47 /

-0.03 (-0.55%)

Intrexon announced that…

Intrexon announced that it will refocus the company on healthcare, change its name to Precigen and, effective immediately, has appointed Helen Sabzevari as president and CEO. The new Precigen will encompass Intrexon's wholly-owned healthcare subsidiaries Precigen, ActoBio Therapeutics, Exemplar Genetics, and its majority ownership interest in Triple-Gene, as well as equity and royalty interests in therapeutics and therapeutic platforms from companies not controlled by Intrexon. Randal Kirk has been appointed executive chairman. Additionally, Intrexon has executed binding agreements to sell its smaller non-healthcare businesses for $65.2M plus certain contingent payment rights and entered into an agreement to sell $35M of its common stock. The proceeds from these transactions, combined with the company's cash and short-term investments on hand at December 31, 2019, approximates $175M thus attaining Intrexon's year-end objective. Sabzevari, who joined Intrexon in 2017 and has served as president of Precigen for the past two years, brings expertise in the research and development of immunotherapies as well as experience translating novel treatments from preclinical stage into the clinic. Under Sabzevari's leadership, the healthcare-focused organization will seek to improve patients' lives with novel therapies that harness transformational approaches in gene and cell therapies, microbe-based biotherapeutics, and regenerative medicine. Two non-healthcare businesses will remain with the company: MBP Titan and the established bovine genetics company, Trans Ova Genetics. The company will continue to evaluate strategic and operational options for these businesses. Requisite actions to change the name of the company from Intrexon to Precigen and its stock symbol from (XON) to (PGEN) have begun.

ShowHide Related Items >><<
XON Intrexon
$5.47 /

-0.03 (-0.55%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
Options
Largest borrow rate increases among liquid names » 08:45
11/25/19
11/25
08:45
11/25/19
08:45
FTR

Frontier Communications

$0.67 /

+0.095 (+16.67%)

, BUD

AB InBev

$79.11 /

+0.445 (+0.57%)

, GDX

VanEck Vectors Gold Miners ETF

$26.76 /

-0.06 (-0.22%)

, MLCO

Melco Resorts & Entertainment

$21.67 /

+0.21 (+0.98%)

, GME

GameStop

$5.66 /

+0.16 (+2.91%)

, MTCH

Match Group

$69.89 /

-0.16 (-0.23%)

, OSTK

Overstock.com

$7.58 /

-0.055 (-0.72%)

, XON

Intrexon

$5.89 /

-0.065 (-1.09%)

, ADT

ADT Inc.

$8.70 /

+0.135 (+1.58%)

, NIO

NIO Inc.

$1.94 /

-0.045 (-2.27%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: Frontier Communications (FTR) 76.12% +4.27, Anheuser Busch (BUD) 3.20% +1.68, Gold Miners ETF (GDX) 1.82% +1.57, Melco Resorts (MLCO) 1.46% +0.50, GameStop (GME) 25.58% +0.33, Match Group (MTCH) 3.41% +0.28, Overstock com (OSTK) 27.09% +0.25, Intrexon (XON) 5.26% +0.21, ADT (ADT) 18.13% +0.17, and NIO (NIO) 58.26% +0.08.

ShowHide Related Items >><<
FTR Frontier Communications
$0.67 /

+0.095 (+16.67%)

06/20/19 Citi
Frontier Communications price target lowered to $1.00 from $1.50 at Citi
02/19/19 Raymond James
Frontier Communications downgraded to Market Perform at Raymond James
02/19/19 Raymond James
Frontier Communications downgraded to Market Perform at Raymond James
01/08/19 Wells Fargo
Frontier downgraded to Underperform from Market Perform at Wells Fargo
BUD AB InBev
$79.11 /

+0.445 (+0.57%)

11/18/19 Redburn
AB InBev upgraded to Neutral from Sell at Redburn
11/12/19 Maxim
Craft Brew downgraded to Hold from Buy at Maxim
11/01/19 RBC Capital
AB InBev price target lowered to EUR72 from EUR89 at RBC Capital
10/28/19 Guggenheim
AB InBev should be bought, especially on weakness, says Guggenheim
GDX VanEck Vectors Gold Miners ETF
$26.76 /

-0.06 (-0.22%)

MLCO Melco Resorts & Entertainment
$21.67 /

+0.21 (+0.98%)

09/17/19 Morgan Stanley
Morgan Stanley cuts Macau mass and VIP growth expectations
09/06/19 JPMorgan
JPMorgan sees number of events hurting Macau gross gaming revenue
07/30/19
Fly Intel: Top five analyst upgrades
07/30/19 Daiwa
Melco Resorts & Entertainment upgraded to Buy from Outperform at Daiwa
GME GameStop
$5.66 /

+0.16 (+2.91%)

10/22/19
GameStop management to meet with Jefferies
09/12/19 Loop Capital
Loop Capital sees 'steep uphill' for recovery at GameStop
09/11/19 Benchmark
GameStop price target cut to $3 after 'Chernobyl experience' Q2 at Benchmark
09/11/19 Baird
GameStop strategy updated but headwinds remain, says Baird
MTCH Match Group
$69.89 /

-0.16 (-0.23%)

11/12/19 Guggenheim
IAC price target lowered to $270 from $300 at Guggenheim
11/11/19 BMO Capital
Match Group price target lowered to $75 from $85 at BMO Capital
11/11/19 Oppenheimer
IAC price target lowered to $270 from $310 at Oppenheimer
11/08/19 JPMorgan
IAC downgraded to Neutral on close of valuation gap at JPMorgan
OSTK Overstock.com
$7.58 /

-0.055 (-0.72%)

11/13/19 DA Davidson
Overstock.com price target lowered to $25 from $48 at DA Davidson
09/26/19 BofA
Aaron's initiated with a Buy at BofA/Merrill
09/19/19 DA Davidson
Overstock.com stake sale by former CEO Byrne a positive, says DA Davidson
07/16/19 Maxim
Overstock.com resumed with a Buy at Maxim
XON Intrexon
$5.89 /

-0.065 (-1.09%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
ADT ADT Inc.
$8.70 /

+0.135 (+1.58%)

05/13/19
Fly Intel: Top five analyst downgrades
05/13/19 Morgan Stanley
ADT Inc. downgraded to Equal Weight from Overweight at Morgan Stanley
03/15/19 Imperial Capital
ADT Inc. price target lowered to $12 from $15 at Imperial Capital
03/12/19 Citi
ADT Inc. downgraded to Neutral from Buy at Citi
NIO NIO Inc.
$1.94 /

-0.045 (-2.27%)

10/04/19
Fly Intel: Top five analyst downgrades
10/04/19 Goldman Sachs
Goldman Sachs downgrades NIO Inc. to Neutral, slashes target to $1.47 from $9.76
10/04/19 Goldman Sachs
NIO Inc. downgraded to Neutral from Buy at Goldman Sachs
09/26/19 Wolfe Research
NIO Inc. downgraded to Peer Perform from Outperform at Wolfe Research
Earnings
Intrexon reports Q3 EPS (35c), consensus (24c) » 07:39
11/12/19
11/12
07:39
11/12/19
07:39
XON

Intrexon

$5.51 /

-0.135 (-2.39%)

Reports Q3 revenue…

Reports Q3 revenue $23.0M, consensus $33M. Cash, cash equivalents, and short-term investments totaled $89.7M and the value of common equity securities totaled $22.8M at September 30. Kirk, the CEO of the company, concluded, "When I became CEO in 2009, when the company entered into its first collaboration in 2011, when it IPO'd in 2013 and through last year's reacquisition of the vast majority of its commercial rights pertaining to its cancer therapeutics programs, healthcare has been our greatest area of investment and potential. When Helen Sabzevari joined us in 2017 as President of Precigen, truly the repository of the original Intrexon technology as well as its most substantial technology acquisitions, we saw great potential if these technologies could be unlocked by a great drug development team. Today we begin to share with the world what Helen and her team have accomplished and, equally importantly, to let you hear this formidable pharmaceutical executive tell you this in her own words."

ShowHide Related Items >><<
XON Intrexon
$5.51 /

-0.135 (-2.39%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
Hot Stocks
Intrexon falls after dismissing accountant, notes 'going concern' language » 16:39
09/16/19
09/16
16:39
09/16/19
16:39
XON

Intrexon

$6.86 /

+0.44 (+6.85%)

On September 10, the…

On September 10, the audit committee of Intrexon dismissed PricewaterhouseCoopers as the company's independent registered public accounting firm, and on September 13, Deloitte & Touche was engaged as Intrexon's independent registered public accounting firm for the fiscal year ending December 31, in each case effective immediately. The audit reports of PwC on the financial statements of the company as of and for the years ended December 31, 2018 and 2017 did not contain any adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope, or accounting principles, except that the report on the company's consolidated financial statements as of and for the year ended December 31, 2018 included an explanatory paragraph expressing substantial doubt about the company's ability to continue as a going concern. Shares of Intrexon are down 5.7% or 39c to $6.45 per share in after-hours trading.

ShowHide Related Items >><<
XON Intrexon
$6.86 /

+0.44 (+6.85%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland
Options
Unusual call flow in option market yesterday » 07:35
08/15/19
08/15
07:35
08/15/19
07:35
M

Macy's

$16.80 /

-2.58 (-13.31%)

, APA

Apache

$20.09 /

-1.83 (-8.35%)

, RF

Regions Financial

$13.65 /

-0.62 (-4.34%)

, XON

Intrexon

$6.54 /

-0.19 (-2.82%)

Notable call activity was…

Notable call activity was cited Wednesday in Macy's (M), Apache (APA), Regions Financial (RF), and Intrexon (XON).

ShowHide Related Items >><<
M Macy's
$16.80 /

-2.58 (-13.31%)

08/15/19 Wedbush
Kohl's price target lowered to $48 from $58 at Wedbush
08/15/19 Deutsche Bank
Macy's price target lowered to $23 from $28 at Deutsche Bank
08/14/19 JPMorgan
JPMorgan downgrades Macy's to Underweight after earnings miss, guidance cut
08/14/19 JPMorgan
Macy's downgraded to Underweight from Neutral at JPMorgan
APA Apache
$20.09 /

-1.83 (-8.35%)

06/03/19 Wolfe Research
Apache upgraded to Peer Perform from Underperform at Wolfe Research
04/05/19 BMO Capital
Apache price target raised to $36 from $30 at BMO Capital
03/06/19 MUFG
Apache 2018 results, capital program 'significant positives', says MUFG
01/16/19 Barclays
Apache initiated with an Underweight at Barclays
RF Regions Financial
$13.65 /

-0.62 (-4.34%)

07/22/19
Regions Financial upgraded to Outperform at Wedbush
07/22/19 Wedbush
Regions Financial upgraded to Outperform from Neutral at Wedbush
07/11/19 BofA
BofA double downgrades Comerica to Underperform, cuts Regions to Neutral
07/11/19 BofA
Regions Financial downgraded to Neutral from Buy at BofA/Merrill
XON Intrexon
$6.54 /

-0.19 (-2.82%)

06/18/19 JMP Securities
Surterra cannabinoid pact a positive for Intrexon, says JMP Securities
03/01/19 Northland
Intrexon downgraded to Market Perform from Outperform at Northland

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.